Figure 4
Figure 4. Tumorigenic potential of SP and MP cells. (A) CB17/SCID mice were subcutaneously inoculated with SP or MP cells from KMS11 cell line at 0.25 × 106, 0.5 × 106, and 106 cells/mouse. (B) CB17/SCID mice were inoculated with SP or MP cells from KMS11 cell line at lower numbers 1 × 103, 10 × 103, and 100 × 103 cells/mouse. (C) CB17/SCID mice were subcutaneously inoculated with SP or MP cells from OPM1 cell line at 0.25 × 106, 0.5 × 106, and 106 cells/mouse. (D) NOD/SCID mice were subcutaneously inoculated with SP and compared with MP cells from KMS11 cell line at 500 × 103, 250 × 103, 100 × 103, 10 × 103, and 1 × 103 cells/mouse. Caliper measurements of tumor diameters were done every 5 days. Representative pictures were performed using camera IVIS 1327 in the Xenogen system.

Tumorigenic potential of SP and MP cells. (A) CB17/SCID mice were subcutaneously inoculated with SP or MP cells from KMS11 cell line at 0.25 × 106, 0.5 × 106, and 106 cells/mouse. (B) CB17/SCID mice were inoculated with SP or MP cells from KMS11 cell line at lower numbers 1 × 103, 10 × 103, and 100 × 103 cells/mouse. (C) CB17/SCID mice were subcutaneously inoculated with SP or MP cells from OPM1 cell line at 0.25 × 106, 0.5 × 106, and 106 cells/mouse. (D) NOD/SCID mice were subcutaneously inoculated with SP and compared with MP cells from KMS11 cell line at 500 × 103, 250 × 103, 100 × 103, 10 × 103, and 1 × 103 cells/mouse. Caliper measurements of tumor diameters were done every 5 days. Representative pictures were performed using camera IVIS 1327 in the Xenogen system.

Close Modal

or Create an Account

Close Modal
Close Modal